• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Hidden costs of skin cancer caused by workplace sun exposure revealed

Bioengineer by Bioengineer
April 26, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Skin cancer cases attributable to work-related sun exposure could be costing millions of dollars, and must be better addressed by policymakers.

A new study, published today in the Journal of Occupational and Environmental Hygiene, has estimated the total and per-case costs of newly diagnosed non-melanoma skin cancers (NMSCs) in Canada in 2011 caused by workplace sun exposure.

Using a range of secondary sources, including official government records and health surveys, researchers revealed the true economic burden of NMSCs, which cost $34.6 million in 2011 Canadian dollars.

These costs were made up of a range of lifetime costs, including healthcare treatment, the impact of time away from work, out-of-pocket expenses, and poor life quality.

Further analyses highlighted the sizeable cost per patient for the two most common types of non-melanoma skin cancer: basal-cell and squamous-cell carcinoma. The figure stood at $5,760 per case for basal-, and $10,555 per case for squamous-cell carcinoma.

One of the few cancers that are increasing in incidence, skin cancers are the most common form of cancer in Canada and other countries with large fair-skinned populations. Roughly one in ten Canadian workers are exposed to solar ultraviolet (UV) radiation at work, and the majority of these spend six hours or more outdoors each day.

With solar UV radiation the main cause of skin cancer, the researchers hope that their landmark findings can persuade policymakers to give greater attention to reducing workplace sun exposure – both within and outside of Canada. The occupations deemed most at risk – construction, farming, and landscaping – are not exclusive to Canada.

As the study's principal investigator, Dr. Emile Tompa, a senior scientist at Canada's Institute for Work & Health, commented: "The findings suggest that policy-makers might give greater priority to reducing sun exposure at work by allocating occupational cancer prevention resources accordingly."

"The results can also raise awareness among policymakers, employers, unions and workers about the significant contribution of workplace sun exposure to skin cancers. These groups can now make a strong cost-benefit argument for inexpensive exposure reduction interventions, such as shade structures, hats and loose clothing, sunscreen, and shift scheduling to reduce the amount of time workers spend in the sun."

The study, which was funded by the Canadian Cancer Society, is the first to comprehensively estimate the economic burden of workplace NMSCs caused by sun exposure in Canada. It is hoped that the approach can be adapted to carry out similar economic burden estimates in other countries.

###

Media Contact

Daniel Pullin
[email protected]
@tandfnewsroom

http://www.taylorandfrancisgroup.com/

http://dx.doi.org/10.1080/15459624.2018.1447118

Share12Tweet8Share2ShareShareShare2

Related Posts

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

February 7, 2026

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

February 7, 2026

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

February 7, 2026

Barriers and Boosters of Seniors’ Physical Activity in Karachi

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.